FDA Advises Consumers about Recalled Drugs from Able Laboratories

FDA Advises Consumers about Recalled Drugs from Able Laboratories

The Food and Drug Administration (FDA) is taking action to ensure that the public is fully aware that Able Laboratories of Cranbury, NJ, is conducting a nationwide recall of all of its manufactured drugs (mostly generic prescription drugs, including drugs containing acetaminophen) because of serious concerns that they were not produced according to quality assurance standards. Able Laboratories has ceased all current production.
Read more

Rollover Warning for Users of 15-Passenger Vans

NHTSA Restates Rollover Warning For Users of 15-Passenger Vans

The National Highway Traffic Safety Administration (NHTSA) today announced new research that reinforces its existing concerns about 15-passenger vans. As a result, NHTSA reissued its consumer advisory for users of 15-passenger vans for the third time in the past four years.
Read more

FTC Bans Bogus Operator from Credit Repair Business

FTC Bans Bogus Operator from Credit Repair Business

An operator who charged consumers for services he did not deliver and misrepresented customers’ credit worthiness to the credit reporting agencies has been banned for life from operating a credit repair business. Settlement of the charges also bars further violation of the Federal Trade Commission Act and the Credit Repair Organizations Act (CROA), and requires the defendant to pay $100,000 in civil penalties.
Read more

Some Weight-Loss Products Don’t Work

Bogus Weight-Loss Products Do Not Work:

Defendants Barred From Making False and Unsubstantiated Weight-Loss Claims

Scarborough, Maine-based defendants are barred from making false or unsubstantiated claims about any weight-loss product or program, dietary supplement, food, or drug, and have agreed to pay $100,000 in consumer redress to settle Federal Trade Commission charges that they made bogus claims about two weight-loss products: gel thin, a topical gel, and Ultra LipoLean, a dietary supplement tablet that purports to block fat. The FTC alleged that the defendants used one or more of the seven bogus “Red Flag” weight-loss claims. The FTC’s ongoing “Red Flag” education campaign provides guidance to assist media outlets and others on spotting false claims in weight-loss ads.
Read more

« Previous Page